Tom Hudson

Investor

Investment Committee Member at FACIT (Fight Against Cancer Innovation Trust)

About

Venture Partner at Versant Ventures and former SVP and Chief Scientific Officer at AbbVie, as well as inaugural President and Scientific Director of OICR. He earned his medical degree from the University of Montreal and received the Order of Canada.

Colleagues at FACIT (Fight Against Cancer Innovation Trust)

Connie Chen

Senior Director, Strategy and Corporate Development at FACIT (Fight Against Cancer Innovation Trust)

David Koehler

Director, Fund Operations at FACIT (Fight Against Cancer Innovation Trust)

David O'Neill

President at FACIT (Fight Against Cancer Innovation Trust)

Elizabeth Douville

Investment Committee Chair at FACIT (Fight Against Cancer Innovation Trust)

Enrico D'Angelo

CFO at Parkwalk Advisors

Francesca Chappell

Chief Finance Officer at BP Marsh & Partners PLC

Kelly Holman

Investment Committee Member at FACIT (Fight Against Cancer Innovation Trust)

Ken Newport

Board Director at FACIT (Fight Against Cancer Innovation Trust)

Frequently asked questions

Who is Tom Hudson?: Venture Partner at Versant Ventures and former SVP and Chief Scientific Officer at AbbVie, as well as inaugural President and Scientific Director of OICR. He earned his medical degree from the University of Montreal and received the Order of Canada.
Where does Tom Hudson work?: Tom Hudson is Investment Committee Member at FACIT (Fight Against Cancer Innovation Trust).